Prescription Drug Cost Provisions of the Inflation Reduction Act

1. Estimating Rebates and Other Discounts Received by Medicare Part D

   
   

   ---

2. Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market

   
   

   ---

3. Share of Net Insulin Expenditures Captured in the US Pharmaceutical Distribution System

   
   

   ---

4. CMS Spending Before and After Confirmed Benefit of Drugs With Accelerated Approval

   
   

   ---

5. Improving Prescription Drug Affordability Through Regulatory Action

   
   

   ---

6. New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges

   
   

   ---

See More